SCHEMBL4921383

SCHEMBL4921383

O=C(Nc1ccc(-c2ccc(C(=O)[C@@H]3CC[C@H]3C(=O)O)s2)cc1)Nc1cc(C(F)(F)F)ccc1F

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 6/20 0.68
KDR P35968 9/20 0.49
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
RIPK1 Q13546 1/20 0.47
FLT3 P36888 5/20 0.46
PDGFRB P09619 4/20 0.46
RET P07949 3/20 0.46
NTRK1 P04629 2/20 0.46
NTRK3 Q16288 2/20 0.46
NTRK2 Q16620 2/20 0.46
LTK P29376 1/20 0.46
CDK8 P49336 1/20 0.46
MAPK14 Q16539 1/20 0.46
AURKB Q96GD4 1/20 0.46
KIT P10721 5/20 0.46
FLT1 P17948 3/20 0.46
LCK P06239 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4923400 0.88 DGAT1 (0.66) DGAT1KDRCA12CA1CA2
SCHEMBL4921384 0.87 DGAT1 (0.52) DGAT1KDRCA12CA1CA2
SCHEMBL4920081 0.86 DGAT1 (0.57) DGAT1KDRFLT3KITFLT1
SCHEMBL4920085 0.86 DGAT1 (0.57) DGAT1KDRFLT3KITFLT1
SCHEMBL4924477 0.84 DGAT1 (0.72) DGAT1KDRRIPK1FLT3PDGFRB
SCHEMBL4924483 0.84 DGAT1 (0.72) DGAT1KDRRIPK1FLT3PDGFRB
SCHEMBL4924491 0.84 DGAT1 (0.72) DGAT1KDRRIPK1FLT3PDGFRB
SCHEMBL4890035 0.81 DGAT1 (1.00) DGAT1KDRCA12CA1CA2
SCHEMBL4923273 0.77 DGAT1 (0.77) DGAT1KDRCA12CA1CA2
SCHEMBL4921622 0.77 DGAT1 (0.77) DGAT1KDRCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US claimed
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme ABBOTT LABORATORIES 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064717-A1 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme DGAT1, DGAT2, DLAT DGAT1 1/4885KDR 4607/4885CA12 4747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.